A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis ...

Findings from the implanted scaffold led researchers to block specific inflammatory molecules, easing disease severity in a ...

A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It also gave University of Michigan researchers a first ...

Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic ...

A Yale University study uncovers how gut bacteria imbalances may trigger multiple sclerosis (MS), offering new insights into ...

Multiple Sclerosis Market Growth is Driven by Advanced Treatment Solutions and Rising Patient PopulationsPune, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Multiple Sclerosis Market Size & Growth Analysis: ...

Gut microbiome plays a significant role in the onset of multiple sclerosis (MS) -- an autoimmune disease that impacts the ce ...

Experts in Australia and New Zealand have published the first consensus guidelines for the care of adults with MS in those ...

A new study has found that the gut microbiome plays a crucial role in the development of multiple sclerosis (MS), an autoimmune disease that affects the central nervous system. The findings may ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

Spasticity in multiple sclerosis was the most common condition cited by the doctors for treatment with medical cannabis, ...

The drug is designed to reduce inflammation in the brain and has been used on MS, cancer and migraine headaches.